We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-2.12%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$284B
AUM Growth
-$3.39B
Cap. Flow
-$3.28B
Cap. Flow %
-1.16%
Top 10 Hldgs %
25.31%
Holding
3,279
New
74
Increased
1,024
Reduced
1,721
Closed
74

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$580M
2
INTC icon
Intel
INTC
+$382M
3
ZTS icon
Zoetis
ZTS
+$256M
4
PM icon
Philip Morris
PM
+$225M
5
HON icon
Honeywell
HON
+$208M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$562M
2
RTX icon
RTX Corp
RTX
+$425M
3
AAPL icon
Apple
AAPL
+$365M
4
UNP icon
Union Pacific
UNP
+$312M
5
MSFT icon
Microsoft
MSFT
+$254M

Sector Composition

Rank Sector Weight
1 Technology 26.53%
2 Healthcare 12.08%
3 Financials 11.17%
4 Consumer Discretionary 10.62%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
2501
Lyell Immunopharma
LYEL
$360M
$1.07M ﹤0.01%
36,563
+7,005
+24% +$333K
TPC
2502
Tutor Perini Cor
TPC
$5.21B
$1.07M ﹤0.01%
136,757
-13,354
-9% -$110K
ALPN
2503
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.07M ﹤0.01%
93,385
-292
-0.3% -$3.59K
SMRT icon
2504
SmartRent
SMRT
$272M
$1.07M ﹤0.01%
408,512
-4,454
-1% -$15.1K
UWMC icon
2505
UWM Holdings
UWMC
$434M
$1.07M ﹤0.01%
219,620
-3,185
-1% -$18.3K
ATEX icon
2506
Anterix
ATEX
$1.94B
$1.06M ﹤0.01%
33,832
-8,339
-20% -$262K
NAPA
2507
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$1.06M ﹤0.01%
103,393
-1,826
-2% -$22.6K
SBGI icon
2508
Sinclair Inc
SBGI
$1.03B
$1.06M ﹤0.01%
94,476
-6,138
-6% -$79.1K
NNOX icon
2509
Nano X Imaging
NNOX
$73.8M
$1.06M ﹤0.01%
161,212
-157,766
-49% -$1.62M
PLPC icon
2510
Preformed Line Products
PLPC
$2.28B
$1.06M ﹤0.01%
6,490
-85
-1% -$14.2K
NECB icon
2511
Northeast Community Bancorp
NECB
$367M
$1.05M ﹤0.01%
71,471
+27,150
+61% +$426K
GEVO icon
2512
Gevo
GEVO
$382M
$1.05M ﹤0.01%
885,135
-27,018
-3% -$39.9K
NPK icon
2513
National Presto Industries
NPK
$989M
$1.05M ﹤0.01%
14,514
-180
-1% -$13.6K
RCEL icon
2514
Avita Medical
RCEL
$240M
$1.05M ﹤0.01%
71,738
-13,260
-16% -$224K
HLLY icon
2515
Holley
HLLY
$384M
$1.04M ﹤0.01%
207,913
CTO
2516
CTO Realty Growth
CTO
$815M
$1.03M ﹤0.01%
63,832
-25,626
-29% -$440K
ORIC icon
2517
Oric Pharmaceuticals
ORIC
$1.4B
$1.02M ﹤0.01%
169,019
USLM icon
2518
United States Lime & Minerals
USLM
$3.44B
$1.02M ﹤0.01%
25,405
-85
-0.3% -$3.54K
PRME icon
2519
Prime Medicine
PRME
$559M
$1.02M ﹤0.01%
106,922
-16,273
-13% -$211K
KIDS icon
2520
OrthoPediatrics
KIDS
$595M
$1.02M ﹤0.01%
31,869
-5,578
-15% -$215K
NRIM icon
2521
Northrim BanCorp
NRIM
$587M
$1.02M ﹤0.01%
102,916
+43,240
+72% +$464K
CRSR icon
2522
Corsair Gaming
CRSR
$1.55B
$1.01M ﹤0.01%
69,768
-4,302
-6% -$69.2K
IRMD icon
2523
iRadimed
IRMD
$1.18B
$1.01M ﹤0.01%
22,809
-4,268
-16% -$198K
ME
2524
DELISTED
23andMe Holding Co
ME
$1.01M ﹤0.01%
51,674
+22,740
+79% +$638K
CSTR
2525
DELISTED
CapStar Financial Holdings, Inc
CSTR
$1.01M ﹤0.01%
71,152
-662
-0.9% -$9.09K

Similar funds

Nuveen's Q3 2023 Portfolio in Review

As of Q3 2023, Nuveen held 3,279 positions worth $284B, down 1.2% from $287B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.5%. Nuveen opened 74 new positions and exited 74, leaving the 3,279-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q3 2023 buy was Primo Water Corporation: 4,446,437 shares worth $61.4M.
  • Nuveen added most to Kenvue in Q3 2023, an estimated $580M increase.
  • Nuveen's biggest Q3 2023 reduction was PepsiCo, cutting an estimated $562M.
  • Nuveen fully exited Life Storage, Inc. in Q3 2023, selling an estimated $77.3M.
  • Nuveen's ten largest holdings make up 25% of its $284B portfolio in Q3 2023.
  • Nuveen opened 74 new positions and closed 74 in Q3 2023.
  • Nuveen's portfolio value fell 1.2% quarter-over-quarter to $284B.

Based on Nuveen's 13F filing for Q3 2023, filed 14 Nov 2023.